Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction.
about
Telomerase deficiency impairs glucose metabolism and insulin secretion"Inflammaging" as a Druggable Target: A Senescence-Associated Secretory Phenotype-Centered View of Type 2 DiabetesTelomere length, pre-eclampsia, and gestational diabetesTelomere Length Maintenance and Cardio-Metabolic Disease Prevention Through Exercise Training.Short telomeres compromise β-cell signaling and survival.Leukocyte telomere length in the Finnish Diabetes Prevention Study.MiR-146a as marker of senescence-associated pro-inflammatory status in cells involved in vascular remodelling.Genetic predisposition to higher body mass index or type 2 diabetes and leukocyte telomere length in the Nurses' Health Study.Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individualsAssociation between telomere length and type 2 diabetes mellitus: a meta-analysis.Telomere dysfunction-related serological markers are associated with type 2 diabetes.Leukocyte telomere length and diabetes status, duration, and control: the 1999-2002 National Health and Nutrition Examination Survey.Differential Telomere Shortening in Blood versus Arteries in an Animal Model of Type 2 Diabetes.Telomere mean length in patients with diabetic retinopathy.Shortened leukocyte telomere length in type 2 diabetes mellitus: genetic polymorphisms in mitochondrial uncoupling proteins and telomeric pathways.Centenarians as super-controls to assess the biological relevance of genetic risk factors for common age-related diseases: a proof of principle on type 2 diabetes.Telomeres and atherosclerosisInteractions between UCP2 SNPs and telomere length exist in the absence of diabetes or pre-diabetes.Leukocyte telomere length and mortality risk in patients with type 2 diabetes.Age related cardiovascular dysfunction and effects of physical activity.Telomere shortening and Alzheimer's disease.Telomeres and human health.The influence of the telomere-telomerase system on diabetes mellitus and its vascular complications.Telomere attrition and diabetes mellitus.Association between telomere length and diabetes mellitus: A meta-analysis.Early life infection, but not breastfeeding, predicts adult blood telomere lengths in the Philippines.Plasminogen activator inhibitor-1 is associated with leukocyte telomere length in American Indians: findings from the Strong Heart Family Study.Telomere length in atherosclerosis and diabetes.Resistance training enhances insulin suppression of endogenous glucose production in elderly women.Common mental disorders and association with telomere length.The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes.Leukocyte telomere length and hemostatic factors in a South African cohort: the SABPA Study.Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study.Leukocyte telomere length is associated with complications of Type 2 diabetes mellitus
P2860
Q24633376-D23B5D49-763C-4E7D-9946-444102398128Q26747251-9A7E94C8-7112-4F7F-8A6B-57A120288125Q28395714-1989E574-B374-4A46-97EF-36F9FF62E567Q30251870-5042CD09-7A9F-4682-ACCE-42A85A726FBCQ33851700-CEFAFCF8-88A6-41B8-9BE8-D4AC1FAAC95FQ34228543-0283EE16-DC15-455B-9C6B-573F9B1B2D8AQ34280968-CC1C85DC-5E96-473C-AFCD-EFB0EA1FAD4EQ34328685-E887F00A-52F7-4F39-9B7D-766AD20CD3B0Q35043697-4E772ACC-9761-4FF1-BCF4-CE9E8632B802Q35053395-C2B70F9D-87F9-4580-833C-43840823D12DQ35225439-C834762B-C699-44FB-B9B1-4EEF9014BCAFQ35792209-4AF06F37-8867-464C-A0CB-02D0F673FE7CQ35983327-298AF180-B534-4930-99BD-617A2BEA5D24Q36376310-864893CB-B3CD-4AA6-B1A6-5AE0B93DF37FQ36660907-C2E0225E-B380-44BE-9978-925107D734DAQ36981498-47980D5D-0825-4F6D-BCE0-7C0BB5D5014FQ37041786-DFFDEF80-0C58-4FA9-B456-7D1A19BCE4BBQ37247893-D3C4E9FE-4C76-43B8-82AB-3F7825E65102Q37588202-11A4CE5D-E59B-4DA1-82EF-E1F1D434B9CBQ38015080-F3C2A647-8C52-4214-A07D-3B488500FE49Q38060615-B59D083C-677E-4601-96C3-E1C815CE5CA0Q38152802-7299D214-8FD6-41FC-AC17-4AA39AE50940Q38353839-90434C03-1D5C-4342-ACF0-F995D284973FQ38790584-367E7AE0-FAF2-49AA-A9E0-6A2A53A61DD3Q38891642-96756DC4-0DF6-4762-AEC1-1F700E776283Q39000241-62318420-EDCE-4516-8D99-611D173912A5Q40257604-01155BA4-F387-49F0-99E2-68851B5711E1Q40286487-D6C7F951-AD06-41F8-AE34-F9A91CB4610BQ48266739-06928200-AC1C-493D-B3E3-4534559B8455Q49679439-25F1A02E-F764-4AC6-A3E8-E8B6EAE05790Q50655055-7ED6389E-21AB-4F98-8FEB-464CDE9866C5Q51034815-FE8A818F-029B-4058-96B4-AFCEC9651BE9Q51286733-08DB0DB5-516D-49AA-92C7-8503A7BC14F7Q58829026-70E458DC-651B-4DC1-ABAC-D35A16CB620D
P2860
Leukocyte telomere shortening in elderly Type2DM patients with previous myocardial infarction.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Leukocyte telomere shortening ...... revious myocardial infarction.
@en
Leukocyte telomere shortening ...... revious myocardial infarction.
@nl
type
label
Leukocyte telomere shortening ...... revious myocardial infarction.
@en
Leukocyte telomere shortening ...... revious myocardial infarction.
@nl
prefLabel
Leukocyte telomere shortening ...... revious myocardial infarction.
@en
Leukocyte telomere shortening ...... revious myocardial infarction.
@nl
P2093
P50
P1433
P1476
Leukocyte telomere shortening ...... revious myocardial infarction.
@en
P2093
Antonio Procopio
Cristina Sirolla
Liana Spazzafumo
Maria Lorenzi
Maurizio Cardelli
Maurizio Marra
Roberto Antonicelli
Roberto Testa
Serena Mariotti
P304
P356
10.1016/J.ATHEROSCLEROSIS.2009.03.034
P577
2009-04-05T00:00:00Z